Ligand validation:4G74

UQ5: 2,3-DIMETHOXY-5-METHYL-6-(3,11,15,19-TETRAMETHYL-EICOSA-2,6,10,14,18-PENTAENYL)-[1,4]BENZOQUINONE

UQ5 is a Ligand Of Interest in 4G74 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4G74_UQ5_A_602	5%	4%	0.335	0.79	3.34	2.42	11	11	9	0	71%	0.7105
4G74_UQ5_B_602	4%	4%	0.334	0.8	3.37	2.3	10	11	17	0	61%	0.6053
4G74_UQ5_A_601	1%	4%	0.441	0.738	3.38	2.29	10	11	5	0	61%	0.6053
4G74_UQ5_B_603	0%	4%	0.444	0.552	3.38	2.26	10	11	12	0	61%	0.6053
4G73_UQ5_A_602	8%	3%	0.194	0.791	3.44	2.72	2	8	0	0	26%	0.2632
2GMH_UQ5_A_612	22%	6%	0.257	0.877	2.61	2.49	15	16	13	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.